Toho Titanium Company, Limited (TYO:5727)

Theseus Pharmaceuticals Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	4,722	4,599	1,880	3,416	2,128	2,534
Cash & Short-Term Investments	4,722	4,599	1,880	3,416	2,128	2,534
Cash Growth	131.93%	144.63%	-44.96%	60.53%	-16.02%	-4.05%
Accounts Receivable	13,666	14,812	19,041	15,391	10,377	7,242
Other Receivables	1,185	1,161	876	812	978	2,151
Receivables	14,851	15,973	19,917	16,203	11,355	9,393
Inventory	43,677	46,811	52,571	42,196	35,195	32,609
Other Current Assets	3,500	2,352	1,375	1,177	580	570
Total Current Assets	66,750	69,735	75,743	62,992	49,258	45,106
Property, Plant & Equipment	55,911	52,066	47,188	45,196	45,404	41,830
Long-Term Investments	1,915	1,993	1,569	1,286	872	824
Other Intangible Assets	615	683	826	1,028	1,255	1,323
Long-Term Deferred Tax Assets	169	301	675	925	1,305	2,065
Other Long-Term Assets	2	2	1	2	1	1
Total Assets	125,362	124,780	126,002	111,429	98,095	91,149
Accounts Payable	3,495	3,763	3,989	3,932	4,061	2,214
Accrued Expenses	544	1,737	1,977	2,341	1,410	567
Short-Term Debt	34,751	32,446	36,142	22,458	20,680	20,271
Current Portion of Leases	8	10	212	211	461	468
Current Income Taxes Payable	40	1,418	1,100	2,257	323	352
Other Current Liabilities	4,545	4,366	4,172	2,966	2,682	3,006
Total Current Liabilities	43,383	43,740	47,592	34,165	29,617	26,878
Long-Term Debt	21,949	20,584	18,372	20,314	17,472	16,352
Long-Term Leases	1	2	1,401	1,612	1,815	2,276
Other Long-Term Liabilities	2,133	2,123	2,089	2,057	2,025	1,184
Total Liabilities	67,466	66,449	69,454	58,148	50,929	46,690
Common Stock	11,963	11,963	11,963	11,963	11,963	11,963
Additional Paid-In Capital	13,023	13,023	13,023	13,022	13,022	13,022
Retained Earnings	33,127	33,518	31,642	28,469	22,389	19,710
Treasury Stock	-78	-78	-78	-77	-77	-77
Comprehensive Income & Other	-139	-95	-2	-230	-266	-291
Total Common Equity	57,896	58,331	56,548	53,147	47,031	44,327
Minority Interest	-	-	-	134	135	132
Shareholders' Equity	57,896	58,331	56,548	53,281	47,166	44,459
Total Liabilities & Equity	125,362	124,780	126,002	111,429	98,095	91,149
Total Debt	56,709	53,042	56,127	44,595	40,428	39,367
Net Cash (Debt)	-51,987	-48,443	-54,247	-41,179	-38,300	-36,833
Net Cash Per Share	-730.44	-680.65	-762.19	-578.58	-538.13	-517.51
Filing Date Shares Outstanding	71.17	71.17	71.17	71.17	71.17	71.17
Total Common Shares Outstanding	71.17	71.17	71.17	71.17	71.17	71.17
Working Capital	23,367	25,995	28,151	28,827	19,641	18,228
Book Value Per Share	813.47	819.58	794.53	746.74	660.80	622.81
Tangible Book Value	57,281	57,648	55,722	52,119	45,776	43,004
Tangible Book Value Per Share	804.82	809.98	782.92	732.29	643.17	604.22

Source: S&P Global Market Intelligence. Standard template. Financial Sources.